
Company Info
Phone(858) 875-1800
Year Established
2007
Ticker
FATE
Exchange
NASDAQ
Contacts
Scott WolchkoBob Valamehr, Ph.D.
CDO
Cindy Tahl, J.D.
General Counsel
Company Description
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.